NYSE:NUS - Nu Skin Enterprises Stock Price, Forecast & News

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Nu Skin Enterprises announced a quarterly dividend on Tuesday, November 5th. Investors of record on Friday, November 29th will be paid a dividend of $0.37 per share on Wednesday, December 11th. This represents a $1.48 annualized dividend and a dividend yield of 3.80%. The ex-dividend date is Wednesday, November 27th. View Nu Skin Enterprises' Dividend History.

Nu Skin Enterprises, Inc. (NYSE:NUS) issued its earnings results on Tuesday, November, 5th. The company reported $0.79 earnings per share for the quarter, beating analysts' consensus estimates of $0.76 by $0.03. The firm had revenue of $590 million for the quarter, compared to analyst estimates of $605.02 million. Nu Skin Enterprises had a return on equity of 23.52% and a net margin of 4.59%. The business's revenue for the quarter was down 13.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.94 EPS. View Nu Skin Enterprises' Earnings History.

Nu Skin Enterprises is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Nu Skin Enterprises.

Nu Skin Enterprises issued an update on its fourth quarter earnings guidance on Tuesday, November, 5th. The company provided earnings per share guidance of $0.68-0.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.91. The company issued revenue guidance of $570-590 million, compared to the consensus revenue estimate of $642.26 million.

7 Wall Street analysts have issued 1-year price targets for Nu Skin Enterprises' shares. Their forecasts range from $40.00 to $70.00. On average, they anticipate Nu Skin Enterprises' share price to reach $50.29 in the next year. This suggests a possible upside of 29.2% from the stock's current price. View Analyst Price Targets for Nu Skin Enterprises.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Nu Skin Enterprises.

Media headlines about NUS stock have been trending somewhat negative on Saturday, according to InfoTrie. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Nu Skin Enterprises earned a news impact score of -1.4 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Nu Skin Enterprises.

Some companies that are related to Nu Skin Enterprises include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Inter Parfums (IPAR), Avon Products (AVP), Prestige Consumer Healthcare (PBH), USANA Health Sciences (USNA), Revlon (REV), Medifast (MED), Nature's Sunshine Products (NATR) and Veru (VERU).

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), Herbalife Nutrition (HLF), Marathon Petroleum (MPC), Baidu (BIDU), Alphabet (GOOG), Netflix (NFLX), Tesla (TSLA), Booking (BKNG) and Caterpillar (CAT).

Nu Skin Enterprises' stock is owned by a variety of of institutional and retail investors. Top institutional investors include State Street Corp (2.46%), Phoenix Holdings Ltd. (1.21%), Millennium Management LLC (0.63%), Assenagon Asset Management S.A. (0.57%), First Trust Advisors LP (0.42%) and Voya Investment Management LLC (0.36%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Edwina D Woodbury, Foulis Greg, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Institutional Ownership Trends for Nu Skin Enterprises.

NUS stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Squarepoint Ops LLC, Russell Investments Group Ltd., State Street Corp, SG Americas Securities LLC, Robeco Institutional Asset Management B.V., Voya Investment Management LLC and First Quadrant L P CA. View Insider Buying and Selling for Nu Skin Enterprises.

NUS stock was purchased by a variety of institutional investors in the last quarter, including Phoenix Holdings Ltd., Assenagon Asset Management S.A., Mackay Shields LLC, State of New Jersey Common Pension Fund D, 1492 Capital Management LLC, Voloridge Investment Management LLC, Empirical Finance LLC and California Public Employees Retirement System. View Insider Buying and Selling for Nu Skin Enterprises.

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NUS stock can currently be purchased for approximately $38.92.

Nu Skin Enterprises has a market capitalization of $2.16 billion and generates $2.68 billion in revenue each year. The company earns $121.88 million in net income (profit) each year or $3.52 on an earnings per share basis. Nu Skin Enterprises employs 4,900 workers across the globe.View Additional Information About Nu Skin Enterprises.

The official website for Nu Skin Enterprises is http://www.nuskinenterprises.com/.

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]